The nature of schizophrenia: signposts to prevention

References

• The global burden of disease, CJL Murray, AD Lopez. Harvard University Press, Boston 1996
   Google Scholar
• DeLisi LE. 100 years of dementia praecox. Schizophrenia Research 1997; 28: 95
   Google Scholar
• Andreasen NC. Understanding the causes of schizophrenia. New England Journal of Medicine 1999; 340: 645–647
   PubMed Web of Science ®Google Scholar
• Jablensky A, McGrath J, Herrman H, et al. People living with psychotic illness: an Australian study. An overview. Overview of the method and results of low prevalence (psychotic) disorders as part of the national survey of mental health and wellbeing. Low Prevalence Disorders Study Group, Commonwealth Department of Health and Age Care, Canberra 1999
   Google Scholar
• Amin A, Singh SP, Brewin J, Jones P, Medley I, Harrison G. Diagnostic stability of first episode psychosis. British Journal of Psychiatry 1999; 175: 537–543
   PubMed Web of Science ®Google Scholar
• Mrazek PJ, Haggarty RJ. Reducing risks for mental disorders: frontiers for preventive intervention research. National Academy Press, Washington, DC 1994
   Google Scholar
• Kraemer HC, Kazein AE, Offord DR, Kessler RC, Jensen PS, Kupfer DJ. Coming to terms with the terms of risk. Archives of General Psychiatry 1997; 54: 337–343
   PubMed Web of Science ®Google Scholar
• Häfner H, Löffler W, Maurer K, Hambrecht M, Ander Heiden W. Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatrica Scandinavica 1999; 100: 105–118
   PubMed Web of Science ®Google Scholar
• Häfner SM, Nowotny B, Loffler W, Ander Heiden W, Maurer K. When and how does schizophrenia produce social deficits?. European Archives of Psychiatry and Clinical Neuroscience 1995; 246: 17–28
   PubMed Web of Science ®Google Scholar
• Eaton WW, Harrison G. Prevention priorities. Current Opinion in Psychiatry 1996; 9: 141–143
   Web of Science ®Google Scholar
• Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. British Medical Journal 1995; 310: 452–454
   PubMed Web of Science ®Google Scholar
• Woods BT. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. American Journal of Psychiatry 1998; 155: 1661–1670
   PubMed Web of Science ®Google Scholar
• Van Os J, Bijl R, Ravelli A. Can the boundaries of psychosis be defined?. Schizophrenia Research 2000; 41: 8
   Google Scholar
• Geddes JR, Lawrie SM. Obstetric complications and schizophrenia: a meta‐analysis. British Journal of Psychiatry 1995; 167: 786–793
   PubMed Web of Science ®Google Scholar
• Lewis SW, Murray RM. Obstetric complications, neurodevelopmental deviance and risk of schizophrenia. Journal of Psychiatric Research 1987; 21: 413–421
   PubMed Web of Science ®Google Scholar
• Susser E, Neugebauer R, Hoek HW, et al. Schizophrenia after prenatal famine: Further evidence. Archives of General Psychiatry 1996; 53: 25–31
   PubMed Web of Science ®Google Scholar
• Jones P, Rodgers B, Murray R, Marmot M. Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 1994; 344: 1398–1402
   PubMed Web of Science ®Google Scholar
• Lane A, Kinsella A, Murphy P, et al. The anthropometric assessment of dysmorphic features in schizophrenia as an index of its developmental origins. Psychological Medicine 1997; 27: 1155–1164
   PubMed Web of Science ®Google Scholar
• Isohanni I, Jaervelin MR, Jones P, Jolelainen J, Isohanni M. Can excellent school performance be a precursor of schizophrenia? A 28‐year follow‐up in the Northern Finland 1966 birth cohort. Acta Psychiatrica Scandinavica 1999; 11: 17–26
   Google Scholar
• Mortensen PB, Pedersen CB, Westergaard T, et al. Effects of family history and place and season of birth on the risk of schizophrenia. New England Journal of Medicine 1999; 340: 603–608
   PubMed Web of Science ®Google Scholar
• Tienari P, Wynne LC, Moring J, et al. The Finnish adoptive family study of schizophrenia: implications for family research. British Journal of Psychiatry 1994; 164: 20–26
   Web of Science ®Google Scholar
• McGorry P, Curry C. Cannabis use as a risk factor for development of psychotic symptoms: a prospective study. Inaugural International Cannabis and Psychosis Conference, Melbourne, February, 16–171999
   Google Scholar
• Phillips L, Yung A, Hearn N, McFarlane C, Hallgren M, McGorry P. Preventive mental health care: accessing the target population. Australian and New Zealand Journal of Psychiatry 1999; 33: 912–917
   PubMed Web of Science ®Google Scholar
• Van Os J, Ravelli A, Nijl RV. Evidence for a psychosis continuum in the general population. Schizophrenia Research 1999; 36: 57
   Web of Science ®Google Scholar
• McGorry P, McFarlane C, Patton G, et al. The prevalence of prodromal symptoms of schizophrenia in adolescence: a preliminary survey. Acta Psychiatrica Scandinavica 1995; 92: 241–249
   PubMed Web of Science ®Google Scholar
• Brewer W, Francey S, Yung A, et al. Cognitive and olfactory deficit: course from high risk to first episode psychosis. Abstract presented at the 9th Biennial Winter Workshop on Schizophrenia, 7–13 February, Davos, Switzerland. Schizophrenia Research 1998; 29: 1–2
   PubMedGoogle Scholar
• McGorry PD, Phillips LJ, Yung AR, et al. A randomised controlled trial of interventions in the pre‐psychotic phase of psychotic disorders. Schizophrenia Research 2000; 41: 9
   Google Scholar
• Wyatt R. Neuroleptics and the natural course of schizophrenia. Schizophrenia Bulletin 1991; 17: 325–351
   PubMed Web of Science ®Google Scholar
• Verdoux H, Bergey C, Assens F, et al. Prediction of duration of psychosis before first admission. European Psychiatry 1998; 13: 346–352
   PubMed Web of Science ®Google Scholar
• Harrigan SM, McGorry PD, Krstev H. Does treatment delay in first‐episode psychosis really matter?. Schizophrenia Research 2000; 41: 177
   Web of Science ®Google Scholar
• Carbone S, Harrigan S, McGorry P, Curry C, Elkins K. Duration of untreated psychosis and 12‐month outcome in first‐episode psychosis: the impact of treatment approach. Acta Psychiatrica Scandinavica 1999; 100: 96–104
   PubMed Web of Science ®Google Scholar
• Johannessen JO, Larsen TK, McGlashan T, Vaglum P. Early intervention in psychosis: the TIPS project, a multi‐centre study in Scandinavia. Psychosis: Psychological approaches and their effectiveness, B Martindale, A Bateman, M Crowe, F Margison. Gaskell, Glasgow 2000
   Google Scholar
• McGlashan T. Duration of untreated psychosis in first‐episode schizophrenia: marker or determinant of course?. Biological Psychiatry 1999; 46: 899–907
   PubMed Web of Science ®Google Scholar
• Helgason L. Twenty years follow‐up of first psychiatric presentation for schizophrenia: what could have been prevented?. Acta Psychiatrica Scandinavica 1990; 81: 231–235
   PubMed Web of Science ®Google Scholar
• McGlashan TH. Early detection and intervention in schizophrenia: editor's introduction. Schizophrenia Bulletin 1996; 22: 197–199
   PubMed Web of Science ®Google Scholar
• Mihalopoulos C, McGorry P, Carter R. Is phase‐specific, community‐oriented treatment of early psychosis an economically viable method of improving outcome?. Acta Psychiatrica Scandinavica 1999; 100: 47–55
   PubMed Web of Science ®Google Scholar
• Cohen P, Cohen J. The clinician's illusion. Archives of General Psychiatry 1984; 41: 1178–1182
   PubMed Web of Science ®Google Scholar
• Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G. One hundred years of schizophrenia: a meta‐analysis of the outcome literature. American Journal of Psychiatry 1994; 151: 1409–1416
   PubMed Web of Science ®Google Scholar
• Andrews G. Efficacy, effectiveness and efficiency in mental health service delivery. Australian and New Zealand Journal of Psychiatry 1999; 33: 316–322
   PubMed Web of Science ®Google Scholar
• Singh BS, McGorry PD. The Second National Mental Health Plan: an opportunity to take stock and move forward. Medical Journal of Australia 1998; 169: 435–437
   PubMed Web of Science ®Google Scholar
• McGorry PD. The MHS Debate. Who should be treated? Burden versus health gain. Australasian Psychiatry 1997; 5: 275–276
   Google Scholar